LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Diagnostica Stago Highlights Max Generation Family of Coagulation Analyzers at MEDLAB Middle East 2021

By LabMedica International staff writers
Posted on 23 Jun 2021
Image: Diagnostica Stago Highlights Max Generation Family of Coagulation Analyzers at MEDLAB Middle East 2021 (Photo courtesy of Diagnostica Stago)
Image: Diagnostica Stago Highlights Max Generation Family of Coagulation Analyzers at MEDLAB Middle East 2021 (Photo courtesy of Diagnostica Stago)
Diagnostica Stago (Asnières-sur-Seine, France), which develops and markets automated systems for blood analysis, highlighted its Max Generation family of coagulation analyzers at MEDLAB Middle East 2021.

On display at the event was the STA R Max 3, a versatile analyzer that will adapt to any type of laboratory set-up, for an equivalent performance whether used alone or integrated into an automated track. It is supported by a range of reagents offering a comprehensive menu of routine and specialized tests, ensuring effective TAT (turnaround time) management. Like its predecessor, the STA R Max 3 has an EPC module for checking sample integrity that controls fill volumes of all types of tubes and detects haemolysed, icteric and lipemic samples to ensure quality results. It requires no additional plasma volume and does not affect throughput.

The company also presented the STA Compact Max 3 which offers significant performance improvements and includes the EPC (expert pre-analytical check) module. This EPC module controls fill volumes of all types of tubes and detects haemolysed, icteric and lipemic samples, allowing the STA Compact Max 3 to check sample integrity to ensure quality results. It requires no additional plasma volume and does not affect throughput. In addition, the company highlighted the STA Satellite Max which builds on the proven strengths of the Max Generation, offering new functionalities and a user-friendly interface, making it the ideal solution for Haemostasis testing in low-volume labs. The STA Satellite Max is a Haemostasis analyzer designed specifically for “satellite” labs looking for a device that meets their needs while guaranteeing results as reliable as those obtained in large specialized laboratories.

At this year’s MEDLAB Middle East, the company showcased the STA R Max 3, a versatile analyzer that will adapt to any type of laboratory set-up, for an equivalent performance whether used alone or integrated into an automated track. It is supported by a range of reagents offering a comprehensive menu of routine and specialized tests, ensuring effective TAT (turnaround time) management.

Related Links:
Diagnostica Stago

Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Laboratory Software
ArtelWare
Automatic Hematology Analyzer
DH-800 Series

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more